What's Next For Insulet Stock? - Nasdaq

Nov 12, 2024 · Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company posted an upbeat Q3 and raised its sales outlook. It reported sales of $544 …

10%
OFF

What's Next For Insulet Stock? - Nasdaq

2 weeks from now

Nov 12, 2024 · Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company posted an upbeat Q3 and raised its sales outlook. It reported sales of $544 …

nasdaq.com

$18
OFF

Are Wall Street Analysts Predicting Insulet Stock Will Climb

2 weeks from now

Nov 27, 2024 · With a market cap of $18.4 billion, Insulet Corporation (PODD) is a global leader in developing innovative insulin delivery systems, including the Omnipod Insulin Management …

nasdaq.com

10%
OFF

What’s Next For Insulet Stock? - Trefis.com

2 weeks from now

Nov 11, 2024 · Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company posted an upbeat Q3 and raised its sales outlook. It reported sales of $544 …

trefis.com

8%
OFF

Insulet’s Promising Growth Trajectory And Strategic Initiatives …

2 weeks from now

Nov 8, 2024 · Overall, these factors combine to support a favorable outlook for Insulet’s stock. According to TipRanks , Wood is a 3-star analyst with an average return of 6.8% and a …

businessinsider.com

13%
OFF

Insulet (PODD) Stock Sinks As Market Gains: What You Should …

2 weeks from now

Jan 13, 2023 · In the latest trading session, Insulet (PODD) closed at $305.89, marking a -0.13% move from the previous day. This change lagged the S&P 500's 0.4% gain on the day. …

nasdaq.com

$9.45
OFF

Insulet (NASDAQ:PODD) Stock Price Expected To Rise, TD

2 weeks from now

Jan 3, 2025 · Insulet Stock Up 3.7 %. PODD traded up $9.45 during mid-day trading on Friday, reaching $266.30. 465,453 shares of the stock were exchanged, compared to its average …

marketbeat.com

8%
OFF

Is Insulet Stock A Smart Addition To Your Portfolio Right Now?

2 weeks from now

Oct 23, 2024 · In the past year, this Zacks Rank #2 (Buy) stock has increased 67.8% compared to a 33.7% rise in the industry. It also outperformed the S&P 500 composite’s 39.2% gain in the …

yahoo.com

26%
OFF

Insulin Device Maker Has Analysts Turning Bullish - Investor's …

2 weeks from now

Jan 7, 2025 · Insulet stock is today's selection for IBD 50 Stocks To Watch. Third-quarter sales accelerated from the previous quarter and increased 26% from the prior year to $543.9 million.

investors.com

$20.12
OFF

Here's Why You Should Retain Insulet (PODD) Stock For Now

2 weeks from now

Jun 21, 2023 · The developer, manufacturer and distributor of insulin delivery systems has a market capitalization of $20.12 billion. Insulet projects a long-term estimated earnings growth …

nasdaq.com

$230.00
OFF

Insulet Co. (NASDAQ:PODD) Receives Average Recommendation …

2 weeks from now

3 days ago · Piper Sandler raised their price target on Insulet from $230.00 to $285.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 17th. Finally, …

marketbeat.com

$304
OFF

Insulet : 2025 JPM Healthcare Conference Presentation

2 weeks from now

9 hours ago · Insulet Corporation Presents at 51st Nasdaq London Investor Conference, Dec-10-2024 10:30 AM Dec. 10: Canaccord Genuity Adjusts Price Target on Insulet to $304 From …

marketscreener.com

22%
OFF

Insulet (PODD) Outperforms Broader Market: What You Need To …

2 weeks from now

Apr 26, 2024 · The the stock of maker of insulin infusion systems has fallen by 4.22% in the past month, leading the Medical sector's loss of 5.2% and undershooting the S&P 500's loss of 3.15%.

nasdaq.com

4%
OFF

Embecta (NASDAQ:EMBC) Stock Price Down 4% - What's Next?

2 weeks from now

11 hours ago · The stock has a market capitalization of $1.14 billion, a PE ratio of 14.48, a PEG ratio of 1.06 and a beta of 1.23. Embecta ( NASDAQ:EMBC - Get Free Report ) last released …

marketbeat.com

6%
OFF

Insulet's Quarterly Earnings Preview: What You Need To Know

2 weeks from now

Oct 21, 2024 · For the full year, analysts expect PODD to report EPS of $3.04, up 10.6% from $2.75 in fiscal 2023.Its EPS is expected to rise 27% year over year to $3.86 in fiscal 2025.

nasdaq.com

5%
OFF

Lineage (NASDAQ:LINE) Stock Price Down 3.5% - What's Next?

2 weeks from now

11 hours ago · Lineage, Inc. (NASDAQ:LINE - Get Free Report) shares fell 3.5% during mid-day trading on Wednesday . The company traded as low as $53.32 and last traded at $53.46. …

marketbeat.com

6%
OFF

Broadcom (NASDAQ:AVGO) Stock Price Up 1.6% - What's Next?

2 weeks from now

1 day ago · Broadcom (NASDAQ:AVGO - Get Free Report) last posted its earnings results on Thursday, December 12th.The semiconductor manufacturer reported $1.42 EPS for the …

marketbeat.com

3%
OFF

Rocket Lab USA (NASDAQ:RKLB) Stock Price Up 6.3% - What's Next?

2 weeks from now

13 hours ago · Also, Director Matthew Ocko sold 2,000,000 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $17.73, for a total value …

marketbeat.com

$18
OFF

Is Insulet Stock Outperforming The Dow? - Nasdaq

2 weeks from now

Dec 27, 2024 · Valued at a market cap of $18.5 billion, Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. …

nasdaq.com

$850
OFF

What's Next For URI Stock? - Nasdaq

2 weeks from now

4 hours ago · URI stock has seen a notable rise in its P/S ratio, from 1.9x in 2020 to 3.4x trailing revenues now. Furthermore, the $850 average of analysts’ price estimate implies an upside of …

nasdaq.com

FAQs about What's Next For Insulet Stock? - Nasdaq Coupon?

Is Insulet Corporation (Podd) a good stock to buy?

Insulet Corporation PODD is driving share gains with its prime Omnipod 5 AID (automated insulin delivery) system, which is highly promising for growth in the upcoming quarters. The company continues to expand the platform to new countries with sensor integrations. A strong solvency position also bodes well for the stock. ...

Is Insulet a good stock to buy?

3.79% of the outstanding shares of Insulet have been sold short. Insulet has a short interest ratio ("days to cover") of 4.8. Short interest in Insulet has recently decreased by 12.79%, indicating that investor sentiment is improving significantly. Insulet does not have a long track record of dividend growth. ...

Are Insulet insiders buying or selling more stock?

In the past three months, Insulet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $252,192.00 in company stock. Only 0.47% of the stock of Insulet is held by insiders. ...

Is insulin a good stock to buy?

The the stock of maker of insulin infusion systems has fallen by 4.22% in the past month, leading the Medical sector's loss of 5.2% and undershooting the S&P 500's loss of 3.15%. The upcoming earnings release of Insulet will be of great interest to investors. The company's earnings report is expected on May 9, 2024. ...

Where does Insulet sell its products?

The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Read More… ...

When will Insulet's earnings release be released?

The upcoming earnings release of Insulet will be of great interest to investors. The company's earnings report is expected on May 9, 2024. The company's upcoming EPS is projected at $0.39, signifying a 69.57% increase compared to the same quarter of the previous year. ...